Open AccessTrichomegaly of eyelashes after treatment with erlotinib in carcinoma pancreas
Author(s) -
Varun Goel,
Shubhra Raina,
D Chandragouda,
Somesh Singh,
Vineet Talwar,
Nivedita Patnaik
Publication year - 2014
Publication title -
international journal of trichology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.494
H-Index - 22
eISSN - 0974-9241
pISSN - 0974-7753
DOI - 10.4103/0974-7753.136755
Subject(s) - erlotinib , medicine , epidermal growth factor receptor , dermatology , pancreatic carcinoma , broad spectrum , oncology , side effect (computer science) , carcinoma , pancreas , pancreatic cancer , cancer , chemistry , computer science , combinatorial chemistry , programming language
Epidermal growth factor receptor (EGFR) inhibitors have been widely used for the treatment of epithelial malignancies. A wide spectrum of skin toxicities have been described in patients receiving EGFR inhibitors. Trichomegaly, especially of the eyelashes is a rare side effect of this therapy. We report a case of trichomegaly of eyelashes in a 39-year-old male, a case of carcinoma pancreas. This side-effect of these medications gives prospects as a therapy to stimulate the growth of hair.